On Jul 13, 2021 an Israeli startup Aidoc closed a Series C round and raised $66,000,000, featuring lead investor General Catalyst.
About the company: Aidoc is located in Tel-Aviv, Israel, Asia. “Proven radiology AI that flags acute pathologies as they enter the workflow. Supporting and enhancing the impact of radiologist diagnostic power.” Aidoc is a provider of artificial intelligence (AI) solutions for medical imaging.
Recently, Aidoc received approval from the U.S. Food and Drug Administration to deploy its algorithms for “adjunctive” detection of findings associated with COVID-19. The models aren’t meant to replace traditional COVID-19 diagnostic tests such as serological tests and nasopharyngeal swabs, but the allowance acknowledges they could be used to prioritize incidental (i.e., non-specific) CT findings tied with COVID-19 infections by isolating anomalies in CT studies containing the lung or part of the lung.
Company website: aidoc.com